OncoSec Medical Inc (ONCSQ)

[chickpea598]

This is the ace up Oncosec's sleeve. When they started the TAP program, the strategy was to get the technology into very capable hands such as Jounce and InhibRX, stir more interest in the technology and than later open up the potential for major licensing deals. Another great value driver in addition to the great potential of the PISCES trial and other indications and partnerships to come after results.